What is a Blood Pressure Validation Study? A Guide for Medical Device Sponsors

What is a Blood Pressure Validation Study? 

Blood pressure devices cannot enter the market based solely on engineering performance or bench testing. Sponsors must demonstrate that device measurements are accurate when compared against validated clinical reference methods. A blood pressure validation study provides the clinical evidence needed to support FDA submissions, CE mark activities, and global regulatory acceptance. 

For cuff-based non-invasive blood pressure devices, validation studies are typically designed around ISO 81060-2, the internationally recognized standard for automated sphygmomanometers.  As blood pressure technologies expand to include wearable and cuffless systems, validation approaches may also extend beyond traditional cuff-based methods to match device output type and intended use. These studies evaluate whether device measurements meet predefined accuracy thresholds across a representative participant population. 

Why Blood Pressure Validation Studies Matter 

Blood pressure measurement accuracy directly affects device credibility, usability, and regulatory success. Validation studies help Sponsors: 

• Demonstrate measurement accuracy 

• Support FDA and CE mark submissions 

• Identify device performance limitations early 

• Reduce regulatory review questions 

• Generate regulator-ready datasets 

• Confirm performance across participant variability 

  
  

What Standards Apply to Blood Pressure Validation? 

ISO 81060-2 Non-invasive sphygmomanometers Part 2: Clinical performance verification of intermittent automated measurement type is the primary standard used for validating automated non-invasive sphygmomanometers. The standard defines: 

• Participant distribution requirements 

• Blood pressure range requirements 

• Reference measurement methodology 

• Observer training expectations 

• Statistical acceptance criteria 

  
  

Sponsors developing cuffless blood pressure devices often need reference methods or supplemental validation strategies that fit their technology, since many cuffless approaches do not map directly to traditional cuff-based validation workflows. ISO 81060-3 addresses continuous non-invasive blood pressure validation and should be considered separately from ISO 81060-7, which is still forthcoming and not yet published. 

How Blood Pressure Validation Studies Are Conducted 

Most validation studies compare investigational device measurements against accepted reference measurements. Typical study activities include: 

Participant Recruitment 

Studies require participants representing a broad range of: 

• Blood pressure values 

• Arm circumferences 

• Age groups 

• Sex distributions 

• Skin tones when optical sensing is involved 

  
  

Careful recruitment planning is critical because ISO standards specify distribution targets that must be achieved. 

Reference Measurements  

Auscultatory reference utilizes dual auscultation where trained observers independently determine systolic and diastolic reference blood pressure measurements from the same cuff deflation. 

For device types that output continuous or beat-to-beat blood pressure values, intra-arterial (arterial line) reference measurements may be required to provide a time-resolved comparator. Arterial line monitoring delivers direct arterial pressure and waveform data, enabling precise time alignment for systolic, diastolic, and mean arterial pressure (MAP) comparisons. 

Sequential or Simultaneous Measurements 

Depending on device type, paired investigational device and reference measurements may be collected: 

• Sequentially 

• Simultaneously 

• Continuously 

• Under controlled physiological conditions 

  
  

Statistical Analysis 

Validation endpoints typically assess: 

• Mean error 

• Standard deviation 

• Bland-Altman agreement 

• Repeatability 

• Outlier performance 

  
  

The final dataset and outputs should be traceable and clearly documented to support regulator-ready reporting. 

Design Considerations in Blood Pressure Validation 

Blood pressure is inherently dynamic. Physiological changes occur rapidly due to: 

• Respiration 

• Movement 

• Stress 

• Temperature 

• Posture changes 

• Arrhythmias 

  
  

These variables are an expected part of real-world physiology, and well-designed validation studies account for them, particularly for continuous or cuffless systems. 

Sponsors achieve stronger outcomes when common study risks are managed proactively, including: 

• Clear protocol alignment from the start 

• Reliable timing and pairing between device and reference measurements 

• Consistent observer technique for auscultatory references 

• Complete, inspection-ready documentation 

  
  

When these elements are recognized early, validation programs run more smoothly and produce cleaner, regulator-ready datasets that support efficient regulatory review. 

Why CRO Experience Matters 

Blood pressure validation requires more than protocol execution. Successful studies depend on operational consistency, physiological expertise, and regulator-ready documentation. Parameters Research Laboratory (PRL) supports device manufacturers through: 

• Clinical trial protocol development 

• ISO 81060-2 aligned study execution 

• Participant recruitment  

• Regulator-ready endpoint design 

• Risk mitigation strategies 

• Multi-site study coordination (if required) 

• Data quality oversight 

  
  

PRL’s physiological monitoring expertise helps device manufacturers navigate the complexities of validating wearable and next-generation blood pressure technologies. 

Conclusion 

A blood pressure validation study is a foundational step in demonstrating that a medical or wearable device can deliver accurate, reliable measurements under controlled clinical conditions. For medical device sponsors and manufacturers developing innovative monitoring technologies, data collection quality directly influences regulatory outcomes and market readiness. 

Call to Action 

Developing a blood pressure device or wearable monitoring platform? Contact PRL to discuss your blood pressure validation strategy, protocol development needs, and regulator-ready clinical study requirements.